Citation Impact
Citing Papers
Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients
2012 Standout
Growth hormone and prolactin stimulate androgen receptor, insulin-like growth factor-I (IGF-I) and IGF-I receptor levels in the prostate of immature rats
1992
Immortalized and tumorigenic adult human prostatic epithelial cell lines: Characteristics and applications part I. Cell markers and immortalized nontumorigenic cell lines
1996
Glucose Modulation of Ischemic Brain Injury: Review and Clinical Recommendations
1996
Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.
1996 Standout
Cushing's syndrome
2015 Standout
A history of prostate cancer treatment
2002
A Markov model of the natural history of prostate cancer
1994
Molecular determinants of resistance to antiandrogen therapy
2003 Standout
Epidemiology of Prostate Cancer
2019 Standout
Phyto-oestrogens and Western Diseases
1997 Standout
Mechanisms of Action and Clinical Uses of Estramustine
1990
Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer
2003 Standout
Visualization of Gene Expression of Short and Long Forms of Prolactin Receptor in Rat Reproductive Tissues
1993
Prolactin Receptor Expression in the Developing Human Prostate and in Hyperplastic, Dysplastic, and Neoplastic Lesions
1999
The development of androgen-independent prostate cancer
2001 Standout
Ultrastructural and cytochemical studies of the effects of prolactin on the lateral prostate and the seminal vesicle of the castrated guinea pig
1992
Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer
1991 Standout
Intra‐articular depot formulation principles: Role in the management of postoperative pain and arthritic disorders
2008
Hyperglycemia: An Independent Marker of In-Hospital Mortality in Patients with Undiagnosed Diabetes
2002 Standout
Age Trends in the Level of Serum Testosterone and Other Hormones in Middle-Aged Men: Longitudinal Results from the Massachusetts Male Aging Study
2002 Standout
Storage of boar semen
2000 Standout
Therapeutic Effects of Xanthine Oxidase Inhibitors: Renaissance Half a Century after the Discovery of Allopurinol
2006 Standout
Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer
2004 Standout
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
2010 Standout
Androgen-independent effects of prolactin on the different lobes of the immature rat prostate
1995
Dynamic regulation of FoxP3 expression controls the balance between CD4+ T cell activation and cell death
2005 StandoutNobel
Up-regulation of Akt3 in Estrogen Receptor-deficient Breast Cancers and Androgen-independent Prostate Cancer Lines
1999 Standout
EFFECT OF INITIAL FREEZING TEMPERATURE, ADDITION OF GLYCEROL AND DILUTION ON THE SURVIVAL AND FERTILIZING ABILITY OF DEEP-FROZEN RAM SEMEN
1975 Standout
Treatment of Prostate Cancer with Gonadotropin-Releasing Hormone Agonists
1986
Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate
1987 Standout
Azole fungicides affect mammalian steroidogenesis by inhibiting sterol 14 alpha-demethylase and aromatase.
2002 Standout
Endocrine Therapy of Breast and Prostate Cancer
1989
Mitotane (o, p′-DDD)
1980
Is there evidence that chemotherapy is of benefit to patients with carcinoma of the prostate?
1985
A critical analysis of response criteria in patients with prostatic cancer treated with CIS-diamminedichloride platinum II
1979
Alzheimer's disease
1998 Standout
Cyclophosphamide (NSC 26271) versus the combination of adriamycin (NSC 123127), 5-fluorouracil (NSC 19893), and cyclophosphamide in the treatment of metastatic prostatic cancer. A randomized trial
1978
Cyclophosphamide versus 5-fluorouracil, doxorubicin, and mitomycin C (FAM') in the treatment of hormone-resistant metastatic carcinoma of the prostate: a preliminary report of a randomized trial.
1985
Prolactin (PRL) and Its Receptor: Actions, Signal Transduction Pathways and Phenotypes Observed in PRL Receptor Knockout Mice
1998 Standout
1 Paracrine interactions in the anterior pituitary
1986
Adrenal cortical carcinoma
1966
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
Plasma estradiol, free testosterone, sex hormone binding globulin binding capacity, and prolactin in benign prostatic hyperplasia and prostatic cancer
1983
International Union of Pharmacology. XXIII. The Angiotensin II Receptors
2000 Standout
Stress Hyperglycemia and Prognosis of Stroke in Nondiabetic and Diabetic Patients
2001 Standout
Prostate Specific Antigen: A Critical Assessment of the Most Useful Tumor Marker for Adenocarcinoma of the Prostate
1991 Standout
A reevaluation of nonhormonal cytotoxic chemotherapy in the treatment of prostatic carcinoma.
1985
THE EFFECTS OF MILK DILUENTS ON THE VIABILITY OF RAM SPERMATOZOA AND THEIR REVIVAL AFTER FREEZING
1960
Prostatic Acid Phosphatase: Its Current Clinical Status
1987
Prostate Specific Antigen in the Preoperative and Postoperative Evaluation of Localized Prostatic Cancer Treated with Radical Prostatectomy
1988
Reactive hyperglycaemia in patients with acute stroke
1976
Proposal for classifying the acute emetogenicity of cancer chemotherapy.
1997 Standout
Acid Phosphatase
1979
Dendritic cells expand antigen‐specific Foxp3+CD25+CD4+ regulatory T cells including suppressors of alloreactivity
2006 StandoutNobel
Elevated Androgens and Prolactin in Aromatase-Deficient Mice Cause Enlargement, But Not Malignancy, of the Prostate Gland*
2001
Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage
2012 Standout
The pathogenesis of benign prostatic hyperplasia
1980 Standout
A Comparison of Estramustine Phosphate Versus Cis-platinum Alone Versus Estramustine Phosphate Plus Cis-platinum in Patients with Advanced Hormone Refractory Prostate Cancer Who Had Had Extensive Irradiation to the Pelvis or Lumbosacral Area
1983
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Assessment of Spermatozoal Function Using Dual Fluorescent Staining and Flow Cytometric Analyses1
1986
Allopurinol amelioration of the pathophysiology of acute myocardial infarction in rats
1981
LNCaP model of human prostatic carcinoma.
1983 Standout
Cisplatin
1984 Standout
Works of Jack Saroff being referenced
Measurements of prolactin and androgens in patients with prostatic disease.
1977
The Continued Evaluation of the Effects of Chemotherapy in Patients with Advanced Carcinoma of the Prostate
1976
Clinical Significance of Serum Alkaline Phosphatase Isoenzyme Levels in Advanced Prostatic Carcinoma
1978
Interference by Glycerol with Differential Staining of Bull Spermatozoa as Used with Semen Thawed from the Frozen State
1954
Two new, direct, and specific methods of acid phosphatase determination National field trial
1979
Comparison of Procarbazine, Imidazole-Carboxamide and Cyclophosphamide in Relapsing Patients with Advanced Carcinoma of the Prostate
1979
Effects of testosterone and prolactin on rat prostatic weight, 5alpha-reductase, and arginase
1975
Disposition and metabolism of intra‐articularly injected 4‐C14‐cortisol in rheumatoid arthritis
1967
EFFECTS OF TRANSPLANTED PITUITARY GLANDS FROM NON-ARTERIOSCLEROTIC VIRGIN AND ARTERIOSCLEROTIC BREEDER DONORS TO HYPOPHYSECTOMIZED RATS
1968
Measurements of Prolactin and Androgens in Patients with Prostatic Diseases
1980
The Use of Estramustine and Prednimustine Versus Prednimustine Alone in Advanced Metastatic Prostatic Cancer Patients Who Have Received Prior Irradiation
1979
Chemotherapy of Advanced Prostatic Carcinoma with Cyclophosphamide or 5-Fluorouracil: Results of First National Randomized Study
1975
A Comparison of Estramustine Phosphate and Streptozotocin in Patients with Advanced Prostatic Carcinoma Who Have Had Extensive Irradiation
1977
Prostatic cancer Evolution of treatment at a comprehensive center (1970–1974)
1976
Prostatic carcinoma treated at a categorical center, 1970--1979.
1975
Chemotherapy of advanced prostatic cancer by the National Prostatic Cancer Group.
1976
Metabolic and histopathological consequences of a fatty liver during the acute stages of myocardial infarction in rats.
1971
Metabolic Changes in Response to Acute Cerebral Ischemia Following Unilateral Carotid Artery Ligation in Arteriosclerotic Versus Nonarteriosclerotic Rats
1970
Steroid Metabolites from Cholesterol-C14in a Patient with Adrenal Cancer: Effects of Metopirone
1963
The Relationship of Egg Yolk and Glycerol Content of Diluters and Glycerol Equilibration Time to Survival of Bull Spermatozoa after Low Temperature Freezing
1955
National randomized study of chemotherapeutic agents in advanced prostatic carcinoma: a progress report.
1977